Publication | Closed Access

Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD)

Percutaneous Transcatheter ApproachPercutaneous Coronary InterventionTranslational MedicineAngiogenesisCardiovascular DiseaseCardiologyVascular BiologyBiomedical EngineeringNeovascularizationVascular Endothelial Growth FactorMedicineAtherosclerosisCoronary Artery DiseaseAcute Myocardial InfarctionCardiovascular Translational Research